SCHEMBL314087

SCHEMBL314087

COc1cccc(-c2nnc3n2-c2ccc(Cl)cc2NC[C@H]3C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
CNR1 P21554 1/20 0.40
PDE10A Q9Y233 2/20 0.38
GLA P06280 1/20 0.38
GCGR P47871 1/20 0.37
MAPK14 Q16539 1/20 0.37
DCTPP1 Q9H773 1/20 0.37
HSD17B3 P37058 1/20 0.37
DYRK1A Q13627 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
PIM1 P11309 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
HTT P42858 1/20 0.36
HIF1A Q16665 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
P2RX7 Q99572 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL314086 1.00 ALDH1A1 (0.45) ALDH1A1CNR1PDE10AGLAGCGR
SCHEMBL314088 1.00 ALDH1A1 (0.45) ALDH1A1CNR1PDE10AGLAGCGR
SCHEMBL315855 0.92 ALDH1A1 (0.45) ALDH1A1CNR1PDE10AGLAGCGR
SCHEMBL314534 0.92 ALDH1A1 (0.40) ALDH1A1CNR1GLAMAPK14PIM1
SCHEMBL315856 0.92 ALDH1A1 (0.45) ALDH1A1CNR1PDE10AGLAGCGR
SCHEMBL314136 0.92 ALDH1A1 (0.40) ALDH1A1CNR1GLAMAPK14PIM1
SCHEMBL314787 0.92 ALDH1A1 (0.45) ALDH1A1CNR1PDE10AGLAGCGR
SCHEMBL314135 0.92 ALDH1A1 (0.40) ALDH1A1CNR1GLAMAPK14PIM1
SCHEMBL313880 0.92 ALDH1A1 (0.40) ALDH1A1DCTPP1DYRK1ACLK4PIM1
SCHEMBL313882 0.92 ALDH1A1 (0.40) ALDH1A1DCTPP1DYRK1ACLK4PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP claimed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US claimed
US-8093240-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2012-01-10 US disclosed
EP-2322527-A1 Triazole derivatives Merck Patent GmbH (DE) 2011-05-18 EP disclosed
US-20080306042-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306042-A1 Triazole Derivatives TGFBR1, TGFBR2, SMAD3 ALDH1A1 2295/4885CNR1 3936/4885PDE10A 3673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.